Cargando…
Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Treatment of DLBCL has improved greatly in recent decades, with thousands of papers published. We conducted a bibliometric analysis of the literature on DLBCL treatment, and discussed cooperation among authors, countries, and...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990428/ https://www.ncbi.nlm.nih.gov/pubmed/35399710 http://dx.doi.org/10.7150/jca.68453 |
_version_ | 1784683370781868032 |
---|---|
author | Duan, Qintong Li, Yufeng Ou, Lijia Li, Yajun Zeng, Ruolan He, Yizi Pan, Tao Chen, Siwei Chen, Huan Zang, Hui Zhou, Hui Xiao, Ling |
author_facet | Duan, Qintong Li, Yufeng Ou, Lijia Li, Yajun Zeng, Ruolan He, Yizi Pan, Tao Chen, Siwei Chen, Huan Zang, Hui Zhou, Hui Xiao, Ling |
author_sort | Duan, Qintong |
collection | PubMed |
description | Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Treatment of DLBCL has improved greatly in recent decades, with thousands of papers published. We conducted a bibliometric analysis of the literature on DLBCL treatment, and discussed cooperation among authors, countries, and institutions, and identified research hotspots for DLBCL treatment. We searched the Web of Science Core Collection (WOSCC) using “Diffuse Large B Cell Lymphoma or DLBCL” and “Treatment or Therapy or Clinical Trial” as the subject terms, and analyzed the publication year, research direction, country/region, institution, author, source publication, distribution of funding institutions, and other conditions provided by the database. In addition, scientometrics software was used to analyze literature citations and cooperative publications. Bibliometric analyses were performed using https://bibliometric.com/app and VOSviewer. Network maps were generated to evaluate collaborations between different authors, countries, institutions, and keywords. A total of 7,255 studies on treatment of DLBCL were retrieved from the WOSCC on February 19, 2021. We found that the number of publications increased gradually from 1999 to 2021, and this trend was relatively stable in the past 3 years. The countries that produced the most publications were the United States, China, and Japan. Among institutions, University of Texas MD Anderson Cancer Center published the most manuscripts. Furthermore, the United States also had the most annual publications, citations, distribution of journal sources, and funding. Cooperative research between countries is also relatively important to treatment of DLBCL. Therapeutic regimens such as CHOP and R-CHOP, and immunotherapy (CAR-T, PD1/PDL1, and CAR-NK, etc.), have received increased attention. Bibliometric analysis of studies related to DLBCL treatment can help researchers and clinical workers quickly understand the hotspots and development trends in this field, and provide reference for the formulation of public health policies. |
format | Online Article Text |
id | pubmed-8990428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-89904282022-04-08 Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study Duan, Qintong Li, Yufeng Ou, Lijia Li, Yajun Zeng, Ruolan He, Yizi Pan, Tao Chen, Siwei Chen, Huan Zang, Hui Zhou, Hui Xiao, Ling J Cancer Research Paper Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Treatment of DLBCL has improved greatly in recent decades, with thousands of papers published. We conducted a bibliometric analysis of the literature on DLBCL treatment, and discussed cooperation among authors, countries, and institutions, and identified research hotspots for DLBCL treatment. We searched the Web of Science Core Collection (WOSCC) using “Diffuse Large B Cell Lymphoma or DLBCL” and “Treatment or Therapy or Clinical Trial” as the subject terms, and analyzed the publication year, research direction, country/region, institution, author, source publication, distribution of funding institutions, and other conditions provided by the database. In addition, scientometrics software was used to analyze literature citations and cooperative publications. Bibliometric analyses were performed using https://bibliometric.com/app and VOSviewer. Network maps were generated to evaluate collaborations between different authors, countries, institutions, and keywords. A total of 7,255 studies on treatment of DLBCL were retrieved from the WOSCC on February 19, 2021. We found that the number of publications increased gradually from 1999 to 2021, and this trend was relatively stable in the past 3 years. The countries that produced the most publications were the United States, China, and Japan. Among institutions, University of Texas MD Anderson Cancer Center published the most manuscripts. Furthermore, the United States also had the most annual publications, citations, distribution of journal sources, and funding. Cooperative research between countries is also relatively important to treatment of DLBCL. Therapeutic regimens such as CHOP and R-CHOP, and immunotherapy (CAR-T, PD1/PDL1, and CAR-NK, etc.), have received increased attention. Bibliometric analysis of studies related to DLBCL treatment can help researchers and clinical workers quickly understand the hotspots and development trends in this field, and provide reference for the formulation of public health policies. Ivyspring International Publisher 2022-03-14 /pmc/articles/PMC8990428/ /pubmed/35399710 http://dx.doi.org/10.7150/jca.68453 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Duan, Qintong Li, Yufeng Ou, Lijia Li, Yajun Zeng, Ruolan He, Yizi Pan, Tao Chen, Siwei Chen, Huan Zang, Hui Zhou, Hui Xiao, Ling Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study |
title | Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study |
title_full | Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study |
title_fullStr | Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study |
title_full_unstemmed | Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study |
title_short | Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study |
title_sort | global research trends on the treatment of diffuse large b-cell lymphoma: a bibliometric and visualized study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990428/ https://www.ncbi.nlm.nih.gov/pubmed/35399710 http://dx.doi.org/10.7150/jca.68453 |
work_keys_str_mv | AT duanqintong globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT liyufeng globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT oulijia globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT liyajun globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT zengruolan globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT heyizi globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT pantao globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT chensiwei globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT chenhuan globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT zanghui globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT zhouhui globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy AT xiaoling globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy |